General Dermatology

Explore recent research that shed light on potential associations and manifestations post-COVID-19 infection or vaccination.

Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.

We spoke with several dermatology experts to gauge their thoughts on Valisure's recent findings of benzene in benzoyl peroxide products--as well as what actions they plan to take moving forward.

AI mobile apps have critical gaps in efficacy, safety, and transparency, according to a new report.

The FDA has assigned a Prescription Drug User Fee Act target action date for August 13.

On March 6, 2024, Valisure, an independent testing laboratory, found high levels of benzene when BPO products were incubated at 37°C, 50°C, and 70°C.

It has been 4 years since the COVID-19 pandemic began. In the time since, there has been plentiful research regarding its implications in dermatology.

The data was presented in a scientific session at the American Academy of Dermatology annual meeting.

With 30 years of clinical dermatology research under her belt, Draelos responds to recent benzene and BPO news in this Q&A.

Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.

A news release from the American Academy of Dermatology addressed skin-related issues that disproportionately affect LGBTQ+ individuals.

Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Arianne Shadi Kourosh, MD, MPH, FAAD, shared pearls on environmental factors that can impact skin aging and pigmentation including visible light, IR radiation, location, and pollution.

Menes Kizoulis shared key highlights from the research conducted alongside leading dermatologists, like Alan Irvine, MD, DSc, and Patricia Farris, MD, MS.

Discover the science behind cosmeceutical advancements and the importance of staying informed for enhanced patient care with Zoe Diana Draelos, MD.

Following the announcement of Valisure's findings related to benzene and benzoyl peroxide acne products, Dermatology Times spoke with David Light, co-founder and president of the laboratory behind the report, to discuss the findings, the role of stability testing requirements, and quelling fear-filled online discourse.

In our March publication, Winter Editor in Chief Christopher Bunick, MD, PhD, delved into the growing concern of benzene in personal care products. This commentary becomes all the more important in light of the recent findings of high levels of benzene in acne products.

Systemic corticosteroids are often used as primary therapy for PG, but alternatives should be considered for their favorable safety profile.

From bug bites to poison ivy, the skin can be exposed to a large spectrum of trouble while patients spend extended time outside.

Research suggests that as metal allergies and implants grow in frequency, some patients may need to consult a dermatologist for treatment.

A recent phase 2 study revealed that the gel could act positively in microcystic lymphatic malformations, which currently have no FDA-approved treatments available.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, reviews how to prevent hand dermatitis.

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

At the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss the best skin cleanser recommendations for their patients.

Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.